- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Richard Snyder Emphasizes the Importance of Care Coordination in Value-Based Contracting
Population health management and coordination of care are integral to value-based contracting, explained Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross.
Population health management and coordination of care are integral to value-based contracting, explained Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross.
Transcript
How important are population health management and coordination of care in value-based contracting?
They’re actually integral to value-based contracting. When we do episode of care payments, we are paying for a period of time and everything that happens in that period of time, so it’s critically important that the right patients are chosen for that episode, that there’s extremely good coordination to prevent leakage out of the system of care to other systems, and ultimately that patients adhere to any medication regimens that they’re prescribed and that post-acute care when the patient goes home for a period of time, that’s included in the episode, is well managed so they don’t bounce back to an emergency room or a hospital or end up having a complication that could have been otherwise avoided if we had been monitoring them more closely.
In today’s world, we have technology, whether it’s video capabilities or Bluetooth enabled monitoring devices to determine whether patients are adhering to their treatment plans and whether they’re having any early signs of a complication that could result in a readmission to the hospital or emergency room or avoidable testing and treatment.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
The Role of Transplant in the Era of Novel MM Therapies: Harsh Parmar, MD
May 17th 2025Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't replaced stem cell transplantation, Harsh Parmar, MD, of Hackensack University Medical Center, explains.
Read More
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
